Grown Rogue International Inc
CNSX:GRIN
Grown Rogue International Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
0.42
1
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Grown Rogue International Inc hold over its rivals?
What risks and challenges
does Grown Rogue International Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Grown Rogue International Inc.
Provide an overview of the primary business activities
of Grown Rogue International Inc.
What unique competitive advantages
does Grown Rogue International Inc hold over its rivals?
What risks and challenges
does Grown Rogue International Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Grown Rogue International Inc.
Provide P/S
for Grown Rogue International Inc.
Provide P/E
for Grown Rogue International Inc.
Provide P/OCF
for Grown Rogue International Inc.
Provide P/FCFE
for Grown Rogue International Inc.
Provide P/B
for Grown Rogue International Inc.
Provide EV/S
for Grown Rogue International Inc.
Provide EV/GP
for Grown Rogue International Inc.
Provide EV/EBITDA
for Grown Rogue International Inc.
Provide EV/EBIT
for Grown Rogue International Inc.
Provide EV/OCF
for Grown Rogue International Inc.
Provide EV/FCFF
for Grown Rogue International Inc.
Provide EV/IC
for Grown Rogue International Inc.
Show me price targets
for Grown Rogue International Inc made by professional analysts.
What are the Revenue projections
for Grown Rogue International Inc?
How accurate were the past Revenue estimates
for Grown Rogue International Inc?
What are the Net Income projections
for Grown Rogue International Inc?
How accurate were the past Net Income estimates
for Grown Rogue International Inc?
What are the EPS projections
for Grown Rogue International Inc?
How accurate were the past EPS estimates
for Grown Rogue International Inc?
What are the EBIT projections
for Grown Rogue International Inc?
How accurate were the past EBIT estimates
for Grown Rogue International Inc?
Compare the revenue forecasts
for Grown Rogue International Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Grown Rogue International Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Grown Rogue International Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Grown Rogue International Inc compared to its peers.
Compare the P/E ratios
of Grown Rogue International Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Grown Rogue International Inc with its peers.
Analyze the financial leverage
of Grown Rogue International Inc compared to its main competitors.
Show all profitability ratios
for Grown Rogue International Inc.
Provide ROE
for Grown Rogue International Inc.
Provide ROA
for Grown Rogue International Inc.
Provide ROIC
for Grown Rogue International Inc.
Provide ROCE
for Grown Rogue International Inc.
Provide Gross Margin
for Grown Rogue International Inc.
Provide Operating Margin
for Grown Rogue International Inc.
Provide Net Margin
for Grown Rogue International Inc.
Provide FCF Margin
for Grown Rogue International Inc.
Show all solvency ratios
for Grown Rogue International Inc.
Provide D/E Ratio
for Grown Rogue International Inc.
Provide D/A Ratio
for Grown Rogue International Inc.
Provide Interest Coverage Ratio
for Grown Rogue International Inc.
Provide Altman Z-Score Ratio
for Grown Rogue International Inc.
Provide Quick Ratio
for Grown Rogue International Inc.
Provide Current Ratio
for Grown Rogue International Inc.
Provide Cash Ratio
for Grown Rogue International Inc.
What is the historical Revenue growth
over the last 5 years for Grown Rogue International Inc?
What is the historical Net Income growth
over the last 5 years for Grown Rogue International Inc?
What is the current Free Cash Flow
of Grown Rogue International Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Grown Rogue International Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
120.5m CAD | 193.6 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
723.1B USD | 35 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
404.4B USD | 13.6 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
206.4B CHF | 9.4 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
1.5T DKK | 10.3 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
173B GBP | 131.4 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
183.4B CHF | 10.1 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
207.9B USD | 8.8 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
183.8B USD | 292.4 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
138.1B USD | 7.5 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CA |
G
|
Grown Rogue International Inc
CNSX:GRIN
|
Average EV/EBITDA:
414.4
193.6
|
N/A | N/A | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
35
|
30%
|
1.2 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
13.6
|
7%
|
1.9 |
|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
9.4
|
5%
|
1.9 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
10.3
|
13%
|
0.8 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
131.4
|
10%
|
13.1 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
10.1
|
5%
|
2 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.8
|
8%
|
1.1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
292.4
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
7.5
|
2%
|
3.8 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.